Targeted Delivery Of A Novel Synthetic Curcumin Analog, EF24 To Glioblastoma And

Targeted Delivery Of A Novel Synthetic Curcumin Analog, EF24 To Glioblastoma And

Sponsor(s)

National Institute of Health

Program Type

R21

Principal Investigator(s)Mamoru Shoji, MD
Dates3/01/2011 - 2/28/2013